GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » 5-Year Yield-on-Cost %

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) 5-Year Yield-on-Cost % : 14.58 (As of May. 15, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group 5-Year Yield-on-Cost %?

Tianjin Pharmaceutical Da Ren Tang Group's yield on cost for the quarter that ended in Mar. 2024 was 14.58.


The historical rank and industry rank for Tianjin Pharmaceutical Da Ren Tang Group's 5-Year Yield-on-Cost % or its related term are showing as below:

SHSE:600329' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.78   Med: 6.61   Max: 21.93
Current: 14.58


During the past 13 years, Tianjin Pharmaceutical Da Ren Tang Group's highest Yield on Cost was 21.93. The lowest was 0.78. And the median was 6.61.


SHSE:600329's 5-Year Yield-on-Cost % is ranked better than
98.8% of 502 companies
in the Drug Manufacturers industry
Industry Median: 2.09 vs SHSE:600329: 14.58

Competitive Comparison of Tianjin Pharmaceutical Da Ren Tang Group's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Pharmaceutical Da Ren Tang Group's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Pharmaceutical Da Ren Tang Group's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Tianjin Pharmaceutical Da Ren Tang Group's 5-Year Yield-on-Cost % falls into.



Tianjin Pharmaceutical Da Ren Tang Group 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Tianjin Pharmaceutical Da Ren Tang Group is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Tianjin Pharmaceutical Da Ren Tang Group  (SHSE:600329) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Tianjin Pharmaceutical Da Ren Tang Group 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Traded in Other Exchanges
Address
No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines